MedTrace Logo

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

NCT03063918 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-02-22

No results posted yet for this study

Summary

This pilot clinical trial studies how well personalized dietary intervention works in managing bowel dysfunction and improving quality of life in stage I-III rectosigmoid cancer survivors. Personalized dietary intervention may help people understand bowel symptoms, identify helpful and troublesome foods for bowel symptoms, adjust diets and food preparation based on food triggers, and coach on healthy diet recommendations after cancer treatment.

Conditions

  • Cancer Survivor
  • Stage I Rectosigmoid Cancer
  • Stage II Rectosigmoid Cancer
  • Stage III Rectosigmoid Cancer

Interventions

OTHER

Informational Intervention

Receive a workbook

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Survey Administration

Ancillary studies

BEHAVIORAL

Telephone-Based Intervention

Receive personalized dietary intervention

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Hope Foundation

    collaborator OTHER

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Virginia Sun, PhD, RN · City of Hope Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-28
Primary Completion
2021-09-07
Completion
2021-09-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063918 on ClinicalTrials.gov